Home
Search results “Neuroendocrine colon cancer stage iii treatment”
Status update: AdVince – a potential treatment for neuroendocrine cancer
 
05:34
A status update on the crowdfunded clinical trials of AdVince, a genetically engineered virus which targets and kills neuroendocrine cancer cells.
Views: 1123 Uppsala universitet
Carcinoid Syndrome - causes, symptoms, diagnosis, treatment, pathology
 
08:29
What is carcinoid syndrome? Carcinoid refers to carcinoid tumors, which cause neuroendocrine cells to secrete hormones, leading to a syndrome that includes symptoms like diarrhea, shortness of breath and flushing. Find more videos at http://osms.it/more. Study better with Osmosis Prime. Retain more of what you’re learning, gain a deeper understanding of key concepts, and feel more prepared for your courses and exams. Sign up for a free trial at http://osms.it/more. Subscribe to our Youtube channel at http://osms.it/subscribe. Get early access to our upcoming video releases, practice questions, giveaways and more when you follow us on social: Facebook: http://osms.it/facebook Twitter: http://osms.it/twitter Instagram: http://osms.it/instagram Thank you to our Patreon supporters: Sumant Nanduri Omar Berrios Alex Wright Sabrina Wong Suzanne Peek Arfan Azam Mingli Féng Osmosis's Vision: Empowering the world’s caregivers with the best learning experience possible.
Views: 28032 Osmosis
What is the long-term outlook for someone with neuroendocrine tumours (NETs?)
 
01:00
This video is intended for an international audience, excluding the United States, Canada and France. Dr Enrique Grande discusses the long-term outlook for people diagnosed with neuroendocrine tumours (NETs). There are several treatment options for NETs available that can be used to help improve the quality of life and to help patients to live longer with NETs. Most patients are able to live their usual lives and go to work as normal. Visit http://www.livingwithnets.com to learn more and find answers to questions such as: “What causes NETs?” and “How are NETs diagnosed?” and “How are NETs treated?” Living with Nets provides information and support for people living with NETs. Dr Grande is a medical oncologist based at Ramon y Cajal University Hospital in Madrid, Spain.
Views: 1704 LivingWithNETs.com
Updates in the management of neuroendocrine cancers
 
30:20
In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Jonathan Strosberg provides an update in the management of neuroendocrine cancers. Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=GDUGI © 2017 Imedex, LLC.
Views: 2774 ImedexCME
Debate: Is there a role for surgical management of metastatic neuroendocrine cancer? - Yes
 
14:38
In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Michael A. Choti argues that there is a role for surgical management of metastatic neuroendocrine cancer. Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=GDUGI © 2017 Imedex, LLC.
Views: 265 ImedexCME
Treatment update on neuroendocrine cancers
 
18:58
In this presentation from the Great Debates in Gastrointestinal Malignancies 2018 conference, Dr. Jonathan Strosberg provides an update on the standard of care for neuroendocrine tumors. Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=GDUGI2018KI © 2018 Imedex, LLC.
Views: 88 ImedexCME
Psychosocial Aspects of Living with Neuroendocrine Cancer: Patient/Caregiver Panel
 
43:11
Patient/Caregiver Panel: Psychosocial Aspects of Living with Neuroendocrine Cancer Neuroendocrine Tumor Patient Education Conference September 10, 2011 Panel: Psychosocial Aspects of Living with Neuroendocrine Cancer Visit: http://stanfordhealthcare.org/
Views: 3781 Stanford Health Care
Pancreatic neuroendocrine neoplasms- causes, symptoms, diagnosis, treatment, pathology
 
09:57
What are pancreatic neuroendocrine neoplasms? Pancreatic neuroendocrine neoplasms are a cancer of neuroendocrine cells that are within the pancreas. Find more videos at http://osms.it/more. Study better with Osmosis Prime. Retain more of what you’re learning, gain a deeper understanding of key concepts, and feel more prepared for your courses and exams. Sign up for a free trial at http://osms.it/more. Subscribe to our Youtube channel at http://osms.it/subscribe. Get early access to our upcoming video releases, practice questions, giveaways and more when you follow us on social: Facebook: http://osms.it/facebook Twitter: http://osms.it/twitter Instagram: http://osms.it/instagram Thank you to our Patreon supporters: Sumant Nanduri Omar Berrios Alex Wright Sabrina Wong Suzanne Peek Arfan Azam Mingli Féng Osmosis's Vision: Empowering the world’s caregivers with the best learning experience possible.
Views: 27600 Osmosis
Advances in NET Treatment
 
01:15:11
NET Research Foundation's (Caring for Carcinoid Foundation) 2015 Neuroendocrine Patient & Caregiver Education Conference at Stanford University
The approach for rare NETs: Appendix and rectal NET
 
23:57
This Congress is the premier global event in the field, encompassing malignancies affecting every component of the gastrointestinal tract and aspects related to the care of patients with gastrointestinal cancer, including screening, diagnosis and the latest management options for common and uncommon tumors. It has been endorsed by leading professional societies and organizations. With the focus on personalized therapy, multidisciplinary management and unraveling molecular mechanisms, the World Congress will educate and update the broad range of experts who participate in the treatment of gastrointestinal cancers, providing a clear overview for treatment. In this tandem presentation by Drs. Aurel Perren and Chris Verslype, the approach for rare NETs (appendix and rectal) are discussed. © 2015 Imedex, LLC.
Views: 469 ImedexCME
Colon Cancer Treatments
 
00:47
Dale Shepard, MD, PhD addresses treatment after you have been diagnosed with colon cancer.
Views: 273 Cleveland Clinic
Current treatment landscape for neuroendocrine tumors
 
00:51
Keith Kerr, BSc, MB, ChB, FRCPath, FRCPE from the University of Aberdeen, Aberdeen, UK discusses the current treatment landscape for neuroendocrine tumors at the annual meeting of the European Lung Cancer Conference (ELCC) 2017, Geneva, Switzerland. The prognosis for neuroendocrine tumors is not very positive as physicians have been unsuccessful in developing specific targeted therapies. Dr Kerr explains how more investigation is required, especially for treatments that involve biomarker testing.
Views: 35 VJOncology
Rare Disease Day Special 2017: Understanding Neuroendocrine Tumors
 
07:12
If you are struggling to get a diagnosis for chronic symptoms like diarrhea, flushing, abdominal pain, fatigue or wheezing, you may want to get tested for Neuroendocrine tumors (NETs). Symptoms vary widely between NET patients and may be confused with Irritable Bowel Syndrome, rosacea, ulcers, Crohn’s disease, allergies or pneumonia. Blood work and urine tests are available, as well as CT, PET and other imaging techniques that can locate and identify NET lesions. New products, such as gallium Ga 68 dotatate for PET imaging have recently been approved by the FDA, and other innovations are on the way. There is a huge gap between the number of patients diagnosed with NETs and the number of people who are living with NETs, but are unaware that they have the disease. Visit: http://www.thebalancingact.com Like: https://www.facebook.com/TheBalancingActFans Follow: https://twitter.com/BalancingActTV #TheBalancingAct #BalancingAct 103714
Views: 4755 TheBalancingAct
Neuroendocrine Carcinoma #NET Awareness
 
04:36
My daughter at the time a 1st year nursing student had an assignment to do a video log. She choose to do it on Neuroendocrine Cancer as I am living with it. Nov 10 is National NET Awareness day. I would like you to take just 5 mins and educated yourself on this chronic cancer.
Views: 912 Denise Sullivan
Neuroendocrine Tumor Clinic - The Nebraska Medical Center
 
05:06
Neuroendocrine tumors are rare and can be difficult to diagnose. Getting proper treatment for patients with these types of tumors can be even more challenging. The Nebraska Medical Center offers a Neuroendocrine Tumor Clinic to treat these difficult cases -- one of a few in the country. Luciano Vargas, MD, an abdominal transplant surgeon that specializes in the surgical management of neuroendocrine tumors at The Nebraska Medical Center, says the clinic sees patients from across the country for evaluation and treatment. "We have several types of surgical techniques that we use to remove the tumor: primary surgical resection, staged hepatectomy resection or liver transplantation." Dr. Vargas joined the staff at The Nebraska Medical Center in July. He attended medical school at the University of Texas Health Sciences Center in San Antonio; completed two years of general surgery residency at the University of Nebraska Medical Center (UNMC) in Omaha; followed by two years of research in intestinal transplantation and a fellowship in liver transplantation. He is also an assistant professor of Surgery at UNMC. The Neuroendocrine Tumor Clinic meets twice monthly and has a growing patient base. Dr. Vargas works in collaboration with a neuroendocrine oncologist, Dr. Jean Grem, MD, and a dedicated nurse, Lucie Case. Patients with carcinoid tumors typically present in the fifth and sixth decade of life and have various presentations, notes Dr. Vargas. Some are asymptomatic while others experience vague symptoms such as abdominal pain and bloating. If individuals have excess hormone production, they can experience diarrhea, flushing spells, heart palpitations and wheezing. A physical examination may show heart valve lesions and signs of niacin-deficiency. "To confirm the presence of a carcinoid cancer will ultimately require a tissue diagnosis," says Dr. Vargas. "Additional studies that are used to follow individuals with carcinoid cancer include 5-HIAA levels in the urine, CT and MRI scans, chromogranin A and an octreotide radiolabelled scan." Surgery to remove the tumor is the first line of treatment. The staged hepatectomy procedure involves removing a portion of the tumor from the liver. A port vein embolism to block the blood supply to the affected part of the liver is then performed to stimulate growth to the unaffected portion. If the carcinoid tumor is unresectable and localized to the liver, the patient may be a possible liver transplant candidate. Liver transplant patients can expect one-, three- and five-year survival rates of 81 percent, 65 percent and 49 percent respectively. The liver transplant program at The Nebraska Medical Center was formed in 1985. With more than 2,500 liver transplants and more than 500 pediatric liver transplants under its belt, it is now one of the most active and advanced centers in the world. If the entire tumor is resected, the patient will continue to be monitored for the rest of his or her life. "These types of tumors tend to recur so we like to see them twice a year with repeat imaging to confirm tumor remission," says Dr. Vargas. He says his clinic works closely with the primary care doctor to follow up with these patients. "We believe that a good communicative relationship is vital to patient outcomes," says Dr. Vargas. "Often our patients are not local or our interaction with them comes down to once or twice a year. So we rely on the primary care physician to be the first responders to any changes in the condition of our neuroendocrine patients. To foster this relationship, we make ourselves easily available by email and phone." For more information, visit www.NebraskaMed.com or call 1-800-922-0000.
Views: 4284 Nebraska Medicine
Dr Sarah Ali - Treatment of Primary and Metastatic Liver Tumors
 
13:03
Medical oncologist Sarah Ali discusses all the options for treating metastatic liver cancer.
Views: 3875 John Brune
Colorectal carcinoma - causes, symptoms, diagnosis, treatment, pathology
 
09:21
What is colorectal carcinoma? Colorectal carcinoma, also known as colon cancer, is when malignant or cancerous cells arise in the large intestines, which includes the colon and rectum. Find more videos at http://osms.it/more. Study better with Osmosis Prime. Retain more of what you’re learning, gain a deeper understanding of key concepts, and feel more prepared for your courses and exams. Sign up for a free trial at http://osms.it/more. Subscribe to our Youtube channel at http://osms.it/subscribe. Get early access to our upcoming video releases, practice questions, giveaways and more when you follow us on social: Facebook: http://osms.it/facebook Twitter: http://osms.it/twitter Instagram: http://osms.it/instagram Thank you to our Patreon supporters: Sumant Nanduri Omar Berrios Alex Wright Sabrina Wong Suzanne Peek Arfan Azam Mingli Féng Osmosis's Vision: Empowering the world’s caregivers with the best learning experience possible.
Views: 20260 Osmosis
The Morphologic Assessment of Rectal Neuroendocrine Tumors
 
09:25
Abstract: The histopathologic features of rectal neuroendocrine tumors (NETs), including size, lymphovascular invasion, invasion of proper muscle, and mitotic rate, have a limited role to play in determining a treatment plan preoperatively. We aimed to investigate the morphologic parameters associated with metastasis, and to evaluate their predictive value. Methods Between January 2000 and May 2011, the medical records and endoscopic findings of 468 patients presenting with rectal NETs at the Samsung Medical Center were analyzed retrospectively. All tumors were classified according to size and endoscopic features such as color, shape, contour, and surface change. Results Twenty-one of the 468 patients (4.5%) with rectal NETs had lymph node (LN) metastasis and 11 patients (2.4%) had distant metastasis. Risk factors for metastasis included tumor size (≥10 mm in diameter), hyperemic change, polypoid lesions, irregular contours, and surface ulceration (p=0.000). Independent risk factors that were predictive of metastasis on multivariate analysis included tumor size (≥10 mm in diameter), hyperemic change, and surface ulceration. As the number of independent risk factors for metastasis increased, the risk of metastasis rose. Conclusions Endoscopic features such as hyperemic change, polypoid lesions, irregular contours, and surface ulcers with tumor size ≥10 mm in diameter are associated with metastasis in rectal NETs. In particular, atypical endoscopic features including hyperemic change, and surface ulcer with tumor size ≥10 mm in diameter may help to predict the risk of metastasis of rectal NETs. Authors Eun Ran Kim, Yun Gyoung Park, Dong Kyung Chang READ THE FULL ARTICLE ON OUR OPEN ACCESS VIDEO JOURNAL & ENCYCLOPEDIA HERE: http://www.sciencedirect.com/science/article/pii/S2212097113000356 Keywords Rectal neuroendocrine tumors; Metastasis; Endoscopic features; Video
Radiotherapy for Rectal Cancer, How Does it Work: Dr  Jeff Olsen
 
21:48
Dr. Jeffrey Olsen of Washington University discusses radiation therapy for rectal cancer and what to expect at SNMMI's 2014 Annual Meeting in St. Louis, Missouri.
Views: 6981 SNMChannel1
Neuroendocrine Tumors - The Nebraska Medical Center
 
06:10
Neuroendocrine tumors are rare and can be difficult to diagnose. Getting proper treatment for patients with these types of tumors can be even more challenging. The Nebraska Medical Center offers a Neuroendocrine Tumor Clinic to treat these difficult cases -- one of a few in the country. Luciano Vargas, MD, an abdominal transplant surgeon that specializes in the surgical management of neuroendocrine tumors at The Nebraska Medical Center, says the clinic sees patients from across the country for evaluation and treatment. "We have several types of surgical techniques that we use to remove the tumor: primary surgical resection, staged hepatectomy resection or liver transplantation." Dr. Vargas joined the staff at The Nebraska Medical Center in July 2012. He attended medical school at the University of Texas Health Sciences Center in San Antonio; completed two years of general surgery residency at the University of Nebraska Medical Center (UNMC) in Omaha; followed by two years of research in intestinal transplantation and a fellowship in liver transplantation. He is also an assistant professor of Surgery at UNMC. The Neuroendocrine Tumor Clinic meets twice monthly and has a growing patient base. Dr. Vargas works in collaboration with a neuroendocrine oncologist, Jean Grem, MD and a dedicated nurse, Lucie Case. Patients with carcinoid tumors typically present in the fifth and sixth decade of life and have various presentations, notes Dr. Vargas. Some are asymptomatic while others experience vague symptoms such as abdominal pain and bloating. If individuals have excess hormone production, they can experience diarrhea, flushing spells, heart palpitations and wheezing. A physical examination may show heart valve lesions and signs of niacin-deficiency. "To confirm the presence of a carcinoid cancer will ultimately require a tissue diagnosis," says Dr. Vargas. "Additional studies that are used to follow individuals with carcinoid cancer include 5-HIAA levels in the urine, CT and MRI scans, chromogranin A and an octreotide radiolabelled scan." Surgery to remove the tumor is the first line of treatment. The staged hepatectomy procedure involves removing a portion of the tumor from the liver. A port-vein embolism to block the blood supply to the affected part of the liver is then performed to stimulate growth to the unaffected portion. If the carcinoid tumor is unresectable and localized to the liver, the patient may be a possible liver transplant candidate. Liver transplant patients can expect one-, three- and five-year survival rates of 81 percent, 65 percent and 49 percent respectively. The liver transplant program at The Nebraska Medical Center was formed in 1985. With more than 2,500 liver transplants and more than 500 pediatric liver transplants under its belt, it is now one of the most active and advanced centers in the world. If the entire tumor is resected, the patient will continue to be monitored for the rest of his or her life. "These types of tumors tend to recur so we like to see them twice a year with repeat imaging to confirm tumor remission," says Dr. Vargas. He says his clinic works closely with the primary care doctor to follow up with these patients. "We believe that a good communicative relationship is vital to patient outcomes," says Dr. Vargas. "Often our patients are not local or our interaction with them comes down to once or twice a year. So we rely on the primary care physician to be the first responders to any changes in the condition of our neuroendocrine patients. To foster this relationship, we make ourselves easily available by email and phone." For more information, visit www.NebraskaMed.com or call 1-800-922-0000.
Views: 3429 Nebraska Medicine
ये लक्षण नजर आए तो समझो पेट का कैंसर है || colon cancer || treatment || colon cancer clinical trials
 
10:02
ये लक्षण नजर आए तो समझो पेट का कैंसर है || colon cancer || और इलाज youtube,ये लक्षण नजर आए तो समझो पेट का कैंसर है,colon cancer,youtube,ये लक्षण नजर आए तो समझो पेट का कैंसर है,colon cancer,इलाज,symptoms of cancer,stomach cancer,mesothelioma cancer,metastatic breast cancer treatment,lung cancer treatment,non small cell lung cancer,colon cancer clinical trials,lung cancer research,treatment for lung cancer,effects of lung cancer,cancer clinical trials,prostate cancer treatment,metastatic breast cancer,kidney cancer treatment,cancer center,breast cancer therapy,colon c,renal cancer इलाज,colonoscopy,lung cancer,breast cancer,ovarian cancer,cancer sign,cancer,cervical cancer,prostate cancer,skin cancer,colon,pancreatic cancer,symptoms of pancreatic cancer,skin cancer pictures,breast cancer symptoms,stages of cancer,thyroid cancer,liver cancer symptoms,symptoms of breast cancer,pancreatic cancer symptoms,symptoms of cancer,esophageal cancer,stomach cancer,about cancer,about lung cancer,adenocarcinoma cancer,adenocarcinoma colon,adenocarcinoma colorectal cancer,adenocarcinoma of colon,adenocarcinoma of colon symptoms,adenocarcinoma of colon treatment,advanced breast cancer,advanced cancer,advanced colon cancer,advanced colon cancer symptoms,advanced lung cancer,all about cancer,all symptoms of bowel cancer,alternative cancer treatments,american cancer,american cancer society,anal cancer,anal cancer symptoms,anti cancer,are all colon tumors cancerous,best cancer treatment,bile duct cancer,bladder cancer,bladder cancer symptoms,bladder cancer treatment,blood cancer,blood cancer symptoms,blood cancer treatment,blood test for colon cancer,bone cancer,bone cancer symptoms,bone cancer treatment,bone marrow cancer,bowel and colon cancer symptoms,bowel cancer,bowel cancer causes,bowel cancer colorectal cancer,bowel cancer location,bowel cancer stages and symptoms,bowel cancer symptoms,bowel cancer symptoms in females,bowel cancer symptoms women,bowel cancer treatment,bowel cancer tumour,bowel cancer women,bowel colon cancer,bowel colon cancer symptoms,bowel malignancy,bowel neoplasm,brain cancer,brain cancer symptoms,brain cancer treatment,breast cancer,breast cancer awareness,breast cancer causes,breast cancer chemotherapy,breast cancer facts,breast cancer foundation,breast cancer information,breast cancer pictures,breast cancer prognosis,breast cancer recurrence,breast cancer research,breast cancer ribbon,breast cancer site,breast cancer society,breast cancer stages,breast cancer statistics,breast cancer survival rate,breast cancer symptoms,breast cancer therapy,breast cancer treatment,breast cancer walk,ca of the colon,can colon cancer be cured,canadian cancer,canadian cancer society,cancer,cancer articles,cancer association,cancer awareness,cancer awareness month,cancer biology,cancer bracelet,cancer care,cancer causes,cancer cell,cancer center,cancer center of america,cancer centers of america,cancer chemotherapy,cancer clinic,cancer clinical trials,cancer colon,cancer colon symptoms,cancer colorectal,cancer council,cancer cure,cancer de colon,cancer definition,cancer del colon,cancer detection,cancer diagnosis,cancer diet,cancer disease,cancer doctor,cancer drugs,cancer du colon,cancer facts,cancer fighting foods,cancer foundation,cancer help,cancer hospital,cancer in dogs,cancer in intestines,cancer in the bowel symptoms,cancer in the colon symptoms,cancer in the intestines,cancer in the intestines symptoms,cancer information,cancer institute,cancer journal,cancer lung,cancer metastasis,cancer news,cancer nutrition,cancer of the colon,cancer of the intestines,cancer of the liver,cancer of the pancreas,cancer on intestine,cancer organizations,cancer pain,cancer patient,cancer pictures,cancer prevention,cancer prognosis,cancer radiation,cancer radiation therapy,cancer radiation treatment,cancer rates,cancer remedies,cancer research,cancer research institute,cancer research uk,cancer resources,cancer ribbon,cancer risk,cancer screening,cancer sign,cancer society,cancer specialist,cancer stages,cancer statistics,cancer support,cancer support groups,cancer surgery,cancer survival,cancer survival rates,cancer survivor,cancer symptom,cancer symptoms,cancer test,cancer therapy,cancer treatment,cancer treatment centers,cancer treatment centers of america,cancer treatment of america,cancer treatment options,cancer tumor,cancer types,cancer vaccine,cancer walk,cancer websites,carcinoma cancer,carcinoma colon symptoms,carcinoma of colon symptoms,carcinoma of intestine,carcinoma of large intestine,carcinoma of the intestine,causes colon cancer,causes of bowel cancer symptoms,causes of cancer,causes of colon cancer,causes of colon cancer in women,causes of colorectal cancer,cervical cancer,cervical cancer symptoms,
Views: 827557 Incursion Information
Neuroendocrine Carcinoma
 
12:25
Rasmussen College PowerPoint Presentation on Neuroendocrine Carcinoma originating in the small intestine with hepatic secondaries.
Views: 4563 Cj Perryman
Carcinoid Tumor – Symptoms of Carcinoid Syndrome and Causes of this Tumor Disease
 
04:23
The Carcinoid tumor is a common carcinoid syndrome for its symptoms and signs. Several infections are known to result of this. Some kinds of the disease can be asymptomatic, meaning that they don't have any indications or symptoms. To know detail subscribe this channel: https://goo.gl/gQL0cj It might be the signals of a totally different disease and should you observe at least one of these symptoms. This video talks about carcinoid tumor, carcinoid syndrome, carcinoid cancer, and kinds of tumor. Carcinoid Tumor Review: Carcinoid tumors are a shape of sluggish-growing most cancers that could rise up in numerous locations at some point of your body. Carcinoid tumors, which might be one subset of tumors referred to as neuroendocrine tumors, usually start within the digestive tract. Carcinoid tumors often do not purpose signs and signs and symptoms till overdue within the sickness. It can produce and launch hormones into your body that motive signs and symptoms and symptoms and signs and symptoms and symptoms together with diarrhea or pores and pores and skin flushing. In later ranges, the tumors every so often produce hormones that may purpose carcinoid syndrome. The syndrome is a flushing of the face, pinnacle chest, diarrhea, and trouble respiration. Carcinoid tumor Symptoms: In some cases, carcinoid tumors don't purpose any signs and symptoms or signs. When they do occur, symptoms and signs and symptoms are typically indistinct and depend on the vicinity of the tumor. Signs and symptoms of carcinoid lung tumors encompass: • Chest aches. • wheezing. • Shortness of breath. • Diarrhea. • Redness or a feeling of warmth for your face and neck (pores and pores and skin flushing). • Weight benefit, specifically across the center and top decrease back. • Pink or purple marks on the pores and pores and skin that seem like stretch marks. Carcinoid tumor Causes: It is no longer easy what reasons carcinoid tumors. In elegant, most cancers happen when a cell develops mutations in its DNA. The mutations permit the mobile to keep growing and dividing when wholesome cells might commonly die. The gathering cells form a tumor. Maximum cancers cells can invade nearby healthy tissue and spread to unique elements of the body. Docs do not know what causes the mutations that might cause carcinoid tumors. However, they recognize that carcinoid tumors growth in neuroendocrine cells. Carcinoid tumor Risk factors: Factors that boom the risk of carcinoid tumors encompass: • Older age. Older adults are more likely to be recognized with a carcinoid tumor than are more youthful human beings or youngsters. • Intercourse. Girls are much more likely than guys to develop carcinoid tumors. Source: 1. http://www.mayoclinic.org/diseases-conditions/carcinoid-tumors/home/ovc-20164792 Watch More: 1. https://www.youtube.com/watch?v=rdoOl_1nXf8 2. https://www.youtube.com/watch?v=ShxEjflyzNc #################################### This Youtube channel associated with a website. You can visit this website and can know more detail about your asking topic. Website: http://newswebbd.com ************************************ There is the all social profile link of this Youtube channel. You can visit and stay with us. Facebook: https://www.facebook.com/newswebbd/ Twitter: https://twitter.com/newswebbd24 Google Plus: https://plus.google.com/+MotasimBillah Pinterest: https://www.pinterest.com/newswebbd/ Reddit: https://www.reddit.com/user/NewsWebBD
Views: 7673 Sumon Info Point
End of Stage 3 Colorectal Cancer, with Only Radiation Treatment Left after Surgery and Metastasis
 
07:43
Natural Healing Education Center/ 82-2-2677-3004, 82-10-5703-3004/ 832, Surak-ro, Beolgok-myeon, Nonsan-si, Chungcheongnam-do, Republic of Korea http://healthcounsel.co.kr/ https://blog.naver.com/seedjuice
Endoscopic Diagnosis and Treatment of Colorectal Carcinoids
 
05:39
Abstract: Rectal carcinoid tumors smaller than 10 mm in diameter and located within the submucosal layer have a negligible risk of lymph node involvement and distant metastasis and are suitable for endoscopic treatment. Here the authors have shown an endoscopic ultrasonography for evaluating the size and depth of carcinoid tumors and endoscopic submucosal dissection for en bloc resection. This article is part of an expert video encyclopedia. READ THE FULL ARTICLE ON OUR OPEN ACCESS VIDEO JOURNAL & ENCYCLOPEDIA HERE: http://www.sciencedirect.com/science/article/pii/S2212097113701432
Carcinoid Tumors
 
03:18
Learn more about carcinoid tumors: http://goo.gl/HePZqf Listen to multiple physicians from NewYork-Presbyterian/Weill Cornell Medical Center discuss carcinoids, a specific type of neuroendocrine tumor. Oncologists, radiologists, and surgeons at NewYork-Presbyterian and Weill Cornell medicine are highly specialized in the treatment of carcinoid tumors, which often form in the GI tract or in organs such as the lungs, pancreas, testicles and ovaries. More on the doctors seen in this video: Dr. Fahey: https://goo.gl/Zqo3FV Dr. Zarnegar: https://goo.gl/fx4E97 Dr. Ruggiero: https://goo.gl/qTFUDf
Pancreatic carcinoma - causes, symptoms, diagnosis, treatment & pathology
 
06:49
What is pancreatic carcinoma? Pancreatic carcinoma refers to cancerous cells forming in the pancreas. Most often cancer forms in the exocrine pancreas, particularly in the ductal epithelial cells, which case it's referred to as pancreatic adenocarcinoma. Find more videos at http://osms.it/more. Study better with Osmosis Prime. Retain more of what you’re learning, gain a deeper understanding of key concepts, and feel more prepared for your courses and exams. Sign up for a free trial at http://osms.it/more. Subscribe to our Youtube channel at http://osms.it/subscribe. Get early access to our upcoming video releases, practice questions, giveaways and more when you follow us on social: Facebook: http://osms.it/facebook Twitter: http://osms.it/twitter Instagram: http://osms.it/instagram Thank you to our Patreon supporters: Alex Wright Omar Berrios Osmosis's Vision: Empowering the world’s caregivers with the best learning experience possible.
Views: 74825 Osmosis
Neuroendocrine Tumor | Betsy’s Story
 
04:49
Betsy Clark was diagnosed with a neuroendocrine cancer in her pancreas and received treatment at Johns Hopkins. Every six months, she boards a plane in Michigan bound for Baltimore for her follow-up visits with her care team at The Johns Hopkins Hospital, including pancreas surgeon Christopher Wolfgang. Betsy tells her story about her diagnosis, treatment—including a Whipple procedure and subsequent total pancreatectomy—and how she takes one day at a time.
Views: 15001 Johns Hopkins Medicine
Neuroendocrine Tumor | Dr. Tony Talebi discusses the Treatment of Neuroendocrine Tumor?"
 
18:36
Dr. Tony Talebi discusses the Treatment of Neuroendocrine Tumors with Dr. Strosberg. For further discussion visit http://www.HemOnc101.com Dr. Tony Talebi is a Board Certified Hematologist/Oncologist and his private practice, Miami Hematology & Oncology Associates, is located at 151 NW 11th Ave, Suite 303W, Florida 33030. Telephone 786-504-3084, Fax 786-304-3086 What is the Treatment of Neuroendocrine Tumors? Neuroendocrine tumors are a heterogeneous group of neoplasms that vary in their appearance, biologic behavior, symptoms, and response to treatment. Several types of neuroendocrine tumors (eg, carcinoid tumors, pancreatic neuroendocrine tumors, medullary thyroid cancers, pheochromocytomas) are characterized by slow growth and frequent secretion of hormones or vasoactive substances. In most cases, these tumors also have typical histologic appearance and are accurately diagnosed with standard pathologic methods (light microscopy and immunohistochemical staining). Other neuroendocrine tumors, typified by small cell carcinoma of the lung, are highly aggressive neoplasms, and are usually advanced when diagnosed. Well differentiated neuroendocrine tumors originating in the gastrointestinal tract (carcinoid, pancreatic neuroendocrine tumors) are the most common neuroendocrine tumors. However, these are not the most common neuroendocrine tumors presenting with unknown primary site, since most are diagnosed at an early stage and cured by surgical resection. Poorly differentiated neuroendocrine tumors are characterized by multiple sites of metastases and rarely produce symptoms related to secretion of bioactive substances. Accurate distinction of well differentiated, indolent tumors from poorly differentiated, aggressive tumors is important, since treatment approaches are different Here, Dr. Tony Talebi discusses the treatment of neuroendocrine tumors with Dr. Jonathan Strosberg, an assitant professor of medicine at the Lee Moffitt Comprehensive Cancer Center and a specialist in neuroendocrine tumors. Dr. Strosberg credentials: Faculty Rank: Assistant Member Titles: Department/Program Affiliations: Experimental Therapeutics Gastrointestinal Tumor Primary Address: H. Lee Moffitt Cancer Center & Research Institute Education & Training: BA, Harvard University, 1995 MD, Cornell University Medical College, 1999 Resident, Georgetown University Hospital, 2001 - General Internal Medicine Fellow, H. Lee Moffitt Cancer Center & Research Institute, 2006 - Medical Oncology & Hematology General Board Certification / SubSpecialty: Internal Medicine / Hematology Internal Medicine / Medical Oncology
Views: 2550 Tony Talebi
Surgical Considerations for Neuroendocrine Tumors
 
04:23
Jonathan R. Strosberg, MD; Heloisa P. Soares, MD; and Timothy J. Hobday, MD, discuss the role of surgery for appropriate patients with neuroendocrine tumors.
Views: 298 OncLiveTV
Treatment with 177-Lu-Octreotate in metastastic disease from neuroendocrine tumor
 
09:01
EFFECTIVITY OF THE TREATMENT WITH 177LU-OCTREOTATE IN A PATIENT WITH MULTISISTEMIC METASTATIC DISEASE FROM A BRONCHIAL NEUROENDOCRINE TUMOR Muñoz Ramón, Pablo Vicente1, Sánchez Romero, Javier1, Teruel Hernández, Esmeralda1 Ramírez Romero, Pablo2 Facultad de Medicina, Universidad de Murcia 1 Estudiante. Facultad de Medicina, Universidad de Murcia 2 Facultativo Especialista de Área. Servicio Cirugía General, Hospital Virgen de la Arrixaca Introduction Radiolabelled somatostatin analogues have recently been introduced for the treatment of advanced neuroendocrine tumors with hepatic metastases with the double objective of reducing hormone overproduction and slowing tumoral progression. We present case of a patient who, after undergoing liver transplantation due to liver metastatic disease, was treated of a recurrence of the primary neuroendocrine tumor with 177Lu-[DOTA⁰, Tyr³]-octreotate. Case presentation 60 years old male who in 2002 presents with symptoms consistent with carcinoid syndrome. An hepatic ultrasonography was performed which showed evidence of liver metastatic disease. A complete assessment of the patient revealed a carcinoid tumor of bronchial origin, which led to the performance of a right upper lobectomy. Once the primary tumor was removed the patient was started on a treatment with somatostatin analogues. After three years following this treatment, in 2005, the size of the hepatic metastases was small enough to indicate liver transplantation, being the surgery performed in October 2005. In 2008, a scintigraphy (OctreoScan) demonstrated bone metastatic disease located in the spine, ribs and both femora. This scenario led us to start a treatment based on 177Lu-[DOTA⁰, Tyr³]-octreotate. 5 cycles were completed between 2008 and 2009 avoiding further tumoral progression. A PET-CT scan in 2011 demonstrated mediastinal linfadenopathy. A mediastinal lymphadenectomy was perform and the malignancy was confirmed by the pathologist. Currently, 13 years after the diagnosis and 10 after the transplantation, the disease is stable in stage IV and the patient enjoys a good quality of life. Discussion and conclusions This case shows how the treatment with 177Lu-[DOTA⁰, Tyr³]-octreotate (DOTATATE) represents a promising tool for the management of inoperable neuroendocrine tumours with established metastatic disease.
Thyroid cancer - causes, symptoms, diagnosis, treatment, pathology
 
13:24
What is thyroid cancer? Thyroid cancer is a type of cancer affecting the thyroid gland. Find more videos at http://osms.it/more. Study better with Osmosis Prime. Retain more of what you’re learning, gain a deeper understanding of key concepts, and feel more prepared for your courses and exams. Sign up for a free trial at http://osms.it/more. Subscribe to our Youtube channel at http://osms.it/subscribe. Get early access to our upcoming video releases, practice questions, giveaways and more when you follow us on social: Facebook: http://osms.it/facebook Twitter: http://osms.it/twitter Instagram: http://osms.it/instagram Thank you to our Patreon supporters: Sumant Nanduri Omar Berrios Alex Wright Sabrina Wong Suzanne Peek Arfan Azam Mingli Féng Osmosis's Vision: Empowering the world’s caregivers with the best learning experience possible.
Views: 22821 Osmosis
Episode 155: Saved From a Cancer Death Sentence By Cannabis Oil and Dietary Changes
 
31:00
When she was diagnosed four years ago with Stage 4 neuroendocrine cancer, Nicole Atchison from Vancouver, Canada was given less than two years to live. She freely admits she was “dying pretty fast”. But, she started taking cannabis oil, made changes to her diet, and is alive today to tell her story. Use next link to contribute to this subtitle www.youtube.com/timedtext_video?ref=share&v=Qnd3zgxL_5c
Views: 2785 Cannabis Health Radio
Pancreatic Tumors: Neuroendocrine and Beyond Pt. 1
 
18:17
Pancreatic Tumors: Neuroendocrine and Beyond
Views: 7164 CTisus
Panel: Neuroendocrine Tumors 101 - A Primer
 
15:19
Panel: Neuroendocrine Tumors 101 - A Primer Neuroendocrine Tumor Patient Education Conference September 10, 2011 Stanford doctor George Fisher, MD, PhD., talks about what a neuroendocrine tumor (NET) is and isn’t, as well as its nomenclature. Watch to learn more about NET 101. Speaker: George Fisher, MD, PhD. Associate Professor, Medical Oncology Learn more: http://stanfordhealthcare.org/medical-conditions/cancer/neuroendocrine-cancer.html Visit: http://stanfordhealthcare.org/
Views: 10463 Stanford Health Care
Surgical treatment of liver metastasis of neuroendocrine tumors (NETs)
 
01:46
Trattamento chirurgico metastasi epatiche da tumori neuroendocrini
Views: 167 Riccardo Memeo
Neuroendocrine, Carcinoid Tumors and Carcinoid Syndrome
 
15:30
Dr. Fraiman discusses the diagnosis and management of carcinoid tumors. http://liverandpancreascancer.com http://livercancersurgeon.com http://whipple-procedure.com
Views: 8410 markfraiman
5. Surgery of Pancreas and Small Bowel, Matt Katz, MD, MD Anderson, NETRF 2018 Houston Conference
 
22:32
In this 12 minute presentation, Dr. Matt Katz, MD Anderson Cancer Center provides a condensed overview of surgical options for NETs. Click "SHOW MORE" to scan for specific topics. Click on time to skip to the topic. See time and topics.... TIME TOPIC 0:45 Anatomy of Upper GI Tract, Pancreas 3:05 Types of Pancreatic Tumors 3:49 Types of Small Bowel Tumors 4:17 Treatment modalities for NET 4:55 How to decide on surgery 5:41 Goals of surgery: curative and palliative 9:37 Types of surgical operations 11:08 Summary 11:41 Q&A 13:20 What to ask your surgeon before surgery 15:12 What to eat after surgery 16:00 How to get ready for surgery, building strength 19:11 Surgeon says cured; Oncologist says not??? 20:43 What is a Whipple? 22:31 Close
What Is The Survival Rate Of Appendix Cancer?
 
00:42
Be a prominent role for the profile of genetic mutations tumors in prognosis 3 aug 2012 cancer is type disease where there are developments abnormal cells body that invade and kill normal they 26 jun 2011 mostly this first symptom appendix. Cancer cancer types appendix statistics url? Q webcache. The majority generally, the prognosis for carcinoid tumors of appendix is very good cancer survival rate. 28 jan 2009 there are some appendix cancer facts that you should be aware of tumors are too large and the cancer has spread, the survival rate for this 16 dec 2016 according to the national cancer institute, based on data from the surveillance, the survival rate of patients with mucinous appendiceal when carcinoid tumors of the appendix are small ( 1 cm in diameter), they may these measures could provide 5 year and 10 year survival rates as high as. Knowing the stage helps doctor to decide what kind of treatment is best and can help predict a patient's prognosis, which chance recovery. At best, this information is useful for 19 dec 2016 carcinoid tumors are the most common, comprising over 50 percent. Cancer what is appendiceal cancer? Appendix cancer you should know. Appendix cancer symptoms, survival rate, prognosis, treatment cancers of the appendix review literatures hindawimoffitt center. Md anderson cancer appendix messages compassacpmp research foundation. Carcinoid tumors and carcinomas are staged differently 7 mar 2017 cancer of the appendix (also known as appendiceal cancer) occurs when cells in success rates initial treatment strategies were calculated. There are we just found out today that the bowel symptoms my wife (who is 55) has had for last 3 weeks due to cancer infiltrating bowel, appendix extremely rare, affecting an estimated 600 1,000 may require more aggressive treatment and patients have a lower survival rate 8 jul 2013 what some common symptoms? Surgery demonstrated durable benefits those who able 4 2012 point blank asked rates are, he said 6 months there man on our street it making educated decision begins with stage, or progression, of disease. Appendix cancer survivor's blog things we don't know. 2017 ncri cancer conference discover the latest researchyou can beat cancer cancerdojoappendix cancer statistics appendix cancer stages and grades no more treatment available for my wife's appendix cancer. If the tumor is larger than 3 centimeters, with or without spreading to other parts of body, 5 year survival also 78. Click here to view the pmp appendix cancer patient resources sheet parts of body, rate growth, ability be completely removed with surgery etc. Five year, appendiceal net specific survival rates were as follows 11 sep 2008 when i was diagnosed with cancer and finally located breast had at least a 90. Things you didn't know about rare appendix cancer. 15 feb 2010 my sister was diagnosed with appendix cancer this past august and has 4 do you know what the survival rate is or any info you can give me? . Googleusercont
Views: 707 Upul Answers
Living with neuroendocrine tumours (NETs): Helen talks about getting diagnosed
 
03:04
This video is intended for an international audience, excluding the United States, Canada and France. Helen talks about how she was diagnosed with neuroendocrine tumours (NETs). Helen describes that her initial reason for seeing her doctor was pain in her side. She was sent to hospital and had many tests before initially being misdiagnosed with colon cancer before her diagnosis of neuroendocrine cancer. In the video, Helen talks about the emotional time spent waiting to receive the correct diagnosis of NETs. Hear more real-life stories at http://livingwithnets.com. Living with NETs provides information and support for people living with NETs and answers questions such as: "What causes NETs?" "What are the symptoms of NETs?" “How are NETs diagnosed?” “How are people with NETs treated?” and "What are carcinoid tumours and carcinoid syndrome?" Living with NETs has been developed by Ipsen in collaboration with those living with NETs and the healthcare professionals who care for them. Ipsen would like to thank everyone for his or her valuable insights and stories. All names used on the website are not necessarily real names.
Views: 1128 LivingWithNETs.com
What Is Limited Stage Lung Cancer?
 
00:45
The content of this 17 nov 2016 what is limited stage small cell lung cancer, are the symptoms, treatments available, and prognosis? . Limited stage lung cancer small cell stages american society. Limited stage disease is small cell lung cancer that confined to one half of the chest, essentially 30 jun 2017 learn how & non are staged and what each means. The cancer has also invaded your lymph 2 apr 2016 patients with limited stage small cell lung will have chemotherapy, thoracic radiation therapy and possibly prophylactic i the is located only in lungs not spread to any nodes. This generally includes cancers that are only in one lung (unless tumors widespread throughout the lung), and might have also reached lymph nodes on same side of chest while cancer may spread to nearby or into tissue between lungs, limited stage means it has not metastasized other organs body. Sclc occurs predominantly in limited stage small cell lung cancer (lsclc) stands out as a disease entity for which the role of radiotherapy has been extensively studied and defined through 10 feb 2016 extensive stage, spread to other side your chest, affecting. Html url? Q webcache. Due to the aggressive nature of small cell lung cancer, about 25 percent patients are diagnosed with disease in limited stage 1 mar 2007 international association for study cancer (iaslc) defines as absence distant metastatic. Many experts have 26 sep 2016 small cell lung cancer (sclc) is a neuroendocrine tumor that represents about 15 percent of all cancers. Mar 2017 limited stage. Limited stage small cell lung cancer initial management uptodate. Many doctors 3 jun 2009 combined modality therapy is the standard care for limited stage small cell lung cancer (ls sclc) and has led to a significant improvement in treatment of changed over past 15 years. Sclc limited stage lung cancer small cell therapeutic options and extensive current chemoradiotherapy treatments verywell. This means that the cancer is only on one side of chest and can be treated with a single radiation field. Limited stage lung cancer. Lung cancer small cell stages prognostic factors for limited stage lung a study of (stages i iii) observations from sclc treatment uptodate. Standard treatment for ls sclc currently 28 apr 2002 while extensive stage small cell lung cancer is not considered curable, some patients with limited disease enjoy many years of 24 may 2016 are traditionally classified as having either or. Extensive stage is used to describe small cell lung cancer that has spread parts of the body such as other lung, bone, brain, or bone marrow. Ctca small cell lung cancer stages american society staging. Lung cancer stages lung answers. Googleusercontent search. Forty underwent pet, 14 did not, and all your lung cancer may have been caused by asbestos. [5] micke et read about what limited stage and extensive stage mean for small cell lung cancer 9 feb 2010 the article discusses the use of irinotecan, cisplatin, and etoposide for th
Views: 10 Duck the Question
[Webinar] Pancreatic Neuroendocrine Tumor (PNET) | Pancreatic Cancer Action Network
 
59:29
This webinar discusses treatment approaches and highlights research developments for pancreatic neuroendocrine tumors (PNETs). PRESENTER: Daniel M. Halperin, MD – The University of Texas MD Anderson Cancer Center RECORDED: Dec. 12, 2017 ################ Do you know someone diagnosed with pancreatic cancer? Direct them to Patient Central for information, resources and hope. Call 877-2-PANCAN, email patientcentral@pancan.org or visit http://pcan.at/pty. Associates are available Monday – Friday, 7 a.m. – 5 p.m. PT. ################ CONNECT WITH US WEBSITE: http://pcan.at/PC FACEBOOK: http://facebook.com/JoinTheFight TWITTER: http://twitter.com/pancan INSTAGRAM: http://instagram.com/pancan YOUTUBE: https://youtube.com/StopPancreaticCancer and MORE: http://pancan.org/social-media ################ ABOUT PANCREATIC CANCER ACTION NETWORK The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes today and to double survival by 2020.
Cancer. Carcinoid Tumors. Risk increased by Proton pump Inhibitors (Omeprozole) and H2 antagonist.
 
05:25
Proton pump Inhibitors(Prilosec, Omeprazole, Prevacid,Nexium, Protonix) and H2 antagonist (cimetidine,Ranitidine) are commonly prescribed for Acid reflux and Gerd without the side effects carefully considered. Haphazardly prescribing these medications can increase the patients risk for: esophageal cancer, Stomach cancer (gastric cancer), small and large intestine, rectal neuroendocrine tumors. Neuroendocrine cancer can occur in the lungs, GI tract, and other endocrine organs. From my experience in with my patients very few people truly over produce Hydrochloric acid. Yet their doctor still prescribe proton pump Inhibitors and H2 antagonist. Its much safer to try a natural approach to treatment your acid reflux and gerd first Cancer is scary one of the best tools to alleviate that fear is knowledge. ----- I have a FREE course on natural treatment of Acid reflux and GERD so you can avoid these medications if they are not necessary for you: http://acid-reflux-and-gerd.com/free-... Dr. Veronica Waks' Course on GERD acid-reflux-and-gerd.com Follow me on Twitter: @doctorveronica Facebook: https://www.facebook.com/pages/Cure-f... Evidence That Proton-Pump Inhibitor Therapy Induces the Symptoms it Is Used to Treat by Kenneth E.L. McColl and Derek Gillen from Division of Cardiovascular & Medical Sciences, University of Glasgow, Gardiner Institute, Glasgow, UK Published Online: June 01, 2009 Link: http://www.gastrojournal.org/article/...
Views: 3292 Acid Reflux and GERD
Carcinoid Treatment - Tammy's Story - The Nebraska Medical Center
 
06:09
At first, Tammy figured her symptoms were just part of turning 50. A few doctors appointments later, and she found the answer was much more serious. Carcinoid tumors on her liver and colon. It first seemed that the slow-growing tumors would give her only five more years to live. Then Tammy's son found a video here on YouTube; the story of a woman very much like Tammy who had beaten the same diagnosis with the help of a liver surgeon at The Nebraska Medical Center. Performing a surgery called "Staged Hepatic Resection," Dr. Jean Botha relies on the liver's ability to regenerate; to grow back. He first removed the primary tumor, and then part of Tammy's diseased liver. That part of the liver soon grows back without tumors. Several months later, the same liver resection was done on the other side. It too grew back tumor-free. Tammy is now healthy and looking forward to many happy years with her family. For more information about the Carcinoid Clinic at The Nebraska Medical Center, visit http://www.nebraskamed.com or call 1-800-922-0000.
Views: 10361 Nebraska Medicine
What are the most common symptoms of neuroendocrine tumours (NETs)?
 
01:57
This video is intended for an international audience, excluding the United States, Canada and France. Dr Rachel Riechelmann talks about the symptoms of neuroendocrine tumours (NETs). In the video she describes how symptoms of NETs depend on several factors, such as where the tumours are located and if they produce hormones or not. The physical presence of NETs in the body may cause nonspecific symptoms of NETs such as pain, nausea and sometimes weight loss. If NETs produce hormones then symptoms will be related to the hormone that they produce. This could include low blood sugar (hypoglycaemia) if NETs are producing insulin or facial flushing and other carcinoid syndrome symptoms if serotonin is produced. Visit http://www.livingwithnets.com to learn more and find answers to questions such as: “What causes NETs?” and “How are NETs diagnosed?” “How are NETs treated?” and "What are carcinoid tumours and carcinoid syndrome?" Living with Nets provides information and support for people living with NETs. Dr Riechelmann is a medical oncologist working at Hospital Sírio-Libanês and Hospital em São Paulo in São Paulo, Brazil.
Views: 3106 LivingWithNETs.com
Carcinoid Cancer Foundation Presents Surgery and Treatment Options
 
09:19
What are the surgical and treatment options for carcinoid and neuroendocrine tumor patients? For patients with tumors that have spread to the liver which therapies should be used to improve quality and quantity of life? How do patients benefit from clinical trials? There is an explosion of technologies coming not only in the diagnostics but also in the treatments of these rare cancers.
Debate: Is there a role for surgical management of metastatic neuroendocrine cancer? - No
 
08:27
In this presentation from the 2017 Great Debates & Updates in GI Malignancies, Dr. Jonathan Strosberg argues that there is not a role for the surgical management of metastatic neuroendocrine cancer. Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=GDUGI © 2017 Imedex, LLC.
Views: 180 ImedexCME